Breast Cancer News and Research

Latest Breast Cancer News and Research

The European mammography systems market

With breast cancer being identified as one of the leading causes of death among European women, several governments have begun to launch extensive screening and awareness programmes across the region. However, some countries have still not implemented the planned programmes due to budgetary or socio-economic constraints.

19 Jan 2005

Avastin available across Europe within the next few weeks

Roche has announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug, for the treatment of patients with previously untreated metastatic colorectal cancer.

16 Jan 2005

Researchers shed new light on the development of cancers, particularly breast and prostate cancer

Researchers at Brown Medical School and Rhode Island Hospital have shed new light on the activation of a protein key to the development of cancers, particularly breast and prostate cancer, the most commonly diagnosed cancers in the United States.

13 Jan 2005

No link between eating fruits and vegetables and a subsequent decreased risk for breast cancer

Contrary to findings in previous studies, new research that includes a large group of women found no link between eating fruits and vegetables and a subsequent decreased risk for breast cancer, according to a study in this week’s JAMA.

12 Jan 2005

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Based on successful animal studies, a novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some human breast cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.

10 Jan 2005

Potential new therapies for cancer and bleeding disorders

Lexicon Genetics announced today that it has advanced two of its drug discovery programs into preclinical development in preparation for investigational new drug (IND) applications.

10 Jan 2005

Why the Mediterranean diet appers to protect against breast cancer

U.S. researchers have uncovered reasons why the Mediterranean diet, with its high intake of oleic acid-rich olive oil, seems to protect against breast cancer. They have also found evidence that oleic acid may have a future role in treatment. The findings are reported (Monday 10 January) in Annals of Oncology.

9 Jan 2005

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.

9 Jan 2005

FDA approves Abraxane for metastatic breast cancer

American Pharmaceutical Partners, Inc. and American Bioscience, Inc. (ABI) announced that the U.S. Food and Drug Administration (FDA) has approved Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in metastatic breast cancer.

9 Jan 2005

Direct modulation of progesterone signaling appears to influence ovarian cancer risk

A woman's risk of ovarian cancer rises significantly if she carries either of two previously unexamined variations in the gene that codes for the progesterone receptor, according to a team of researchers led by scientists from the Keck School of Medicine of the University of Southern California.

5 Jan 2005

Study shows women with invasive lobular carcinoma may not need chemotherapy before surgery

Women with a rare type of advanced breast cancer who do not benefit from primary (pre-surgical) chemotherapy still have been found to do better in the long run than patients with a more common advanced breast cancer who do respond to chemotherapy.

3 Jan 2005

Patients with cancer detected on screening mammography undergo less toxic treatment

Women who have their breast cancers detected by physical examinations are at least twice as likely to undergo toxic treatments than those who have their cancer detected by mammography—regardless of the age of the woman, a new study shows.

28 Dec 2004

Pharmacogenomics, has the potential to spark a major, technology-driven restructuring of the health care and pharmaceuticals industries

Pharmacogenomics, the study of genetic variability in the way individuals respond to medicines, has the potential to spark a major, technology-driven restructuring of the health care and pharmaceuticals industries

21 Dec 2004

Many women at high risk for breast cancer are foregoing tamoxifen

Many women at high risk for breast cancer are foregoing tamoxifen, the first FDA-approved drug for prevention of breast cancer, due to concerns about side effects, increased risk of other cancers, and lack of information, a new study by researchers in Boston shows. The study was published in the December 14 in the Journal of Clinical Oncology.

20 Dec 2004

Polls show more teen girls see "alcopop" ads than women age 31-44

The American Medical Association (AMA) released the results of two nationwide polls today that reveal the extent of underage consumption and marketing exposure to "alcopops" or so-called "girlie drinks." The AMA expressed concern that hard-liquor brands are using these sweet-flavored malt beverages as "gateway" beverages to attract less-experienced drinkers.

20 Dec 2004

How radiation therapy is used to safely and effectively treat various cancers

To help cancer patients and their families better understand their treatment options before making a decision, the American Society for Therapeutic Radiology and Oncology has published seven patient information brochures that explain how radiation therapy is used to safely and effectively treat various cancers.

16 Dec 2004

Landmark studies that may change the treatment standards for breast cancer

The 27th Annual San Antonio Breast Cancer Symposium that took place December 8-11 included the presentation of several landmark studies that may change the treatment standards for breast cancer.

14 Dec 2004

New approach to genomic testing identifies women with low risk of breast cancer recurrence

An initial validation study presented by Exagen Diagnostics at the San Antonio Breast Cancer Symposium suggests it may soon be possible to distinguish good prognosis from poor prognosis in any newly diagnosed breast cancer patient based on DNA changes in the patient's tumor.

13 Dec 2004

Women over the age of 60 with low-risk breast cancer may not need to receive radiation therapy after surgery

The current treatment standard recommended for most women with early stage breast cancer is breast conservation therapy, consisting of lumpectomy following by radiotherapy. The purpose of the radiotherapy is to kill any tumor cells in the remaining breast area that may have been missed by the surgery.

13 Dec 2004

Study of early stage breast cancer patients identifies women at low risk of breast cancer mortality

Kaiser Permanente researchers are presenting results of a large epidemiologic study of a unique breast cancer test at the 27th Annual San Antonio Breast Cancer Symposium. The KP study shows the test can identify patients with early stage disease who are at low risk of breast cancer death at 10-years.

13 Dec 2004

Breast Cancer News and Research

Latest Breast Cancer News and Research

The European mammography systems market

Avastin available across Europe within the next few weeks

Researchers shed new light on the development of cancers, particularly breast and prostate cancer

No link between eating fruits and vegetables and a subsequent decreased risk for breast cancer

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Potential new therapies for cancer and bleeding disorders

Why the Mediterranean diet appers to protect against breast cancer

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

Direct modulation of progesterone signaling appears to influence ovarian cancer risk

Study shows women with invasive lobular carcinoma may not need chemotherapy before surgery

Patients with cancer detected on screening mammography undergo less toxic treatment

Pharmacogenomics, has the potential to spark a major, technology-driven restructuring of the health care and pharmaceuticals industries

Many women at high risk for breast cancer are foregoing tamoxifen

Polls show more teen girls see "alcopop" ads than women age 31-44

How radiation therapy is used to safely and effectively treat various cancers

Landmark studies that may change the treatment standards for breast cancer

New approach to genomic testing identifies women with low risk of breast cancer recurrence

Women over the age of 60 with low-risk breast cancer may not need to receive radiation therapy after surgery

Study of early stage breast cancer patients identifies women at low risk of breast cancer mortality

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Breast Cancer News and Research

Latest Breast Cancer News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in